Sigman (ASX:SIG) - CEO and Managing Director, Vikesh Ramsunder
CEO and Managing Director, Vikesh Ramsunder
Incoming Managing Director and CEO, Vikesh Ramsunder Source: Clicks Group Facebook
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Sigma Healthcare (SIG) appoints a new Managing Director and CEO to lead the company
  • Current Group CEO of the Clicks Group in South Africa, Vikesh Ramsunder, will take the helm of the company, with a $1 million per annum remuneration
  • The appointment follows an extensive search process after Sigma’s current CEO, Mark Hooper, announced he would step down at the end of October
  • Mr Ramsunder will commence his role with Sigma in February 2022 following the completion of his notice period
  • Sigma Healthcare is trading 1.64 per cent lower at 60 cents at 11:37 am AEST

Sigma Healthcare (SIG) has appointed a new Managing Director and CEO to lead the company.

Current Group CEO of the Clicks Group in South Africa, Vikesh Ramsunder, will take the helm of the company. The appointment comes with a $1 million per annum remuneration and sign on rights of $1,400,000, vested in two equal tranches. Short and long term incentives will also be offered, if performance targets are met.

Sigma Chairman Ray Gunston said the board was delighted to announce that someone of Mr Ramsunder’s calibre would be leading the company into the future.

“He was a compelling candidate who comes with extensive experience in wholesaling, logistics, pharmacy and retail,” Mr Gunston said.

“He has been integral to the growth of the Clicks Group, which is now one of the largest wholesale, pharmacy and retail operations in Africa, with a market capitalisation around $6 billion, the equivalent of an ASX100 company in Australia.”

The appointment follows an extensive search process after Sigma’s current CEO, Mark Hooper, announced he would be stepping down. Mark Hooper will remain with Sigma until the end of October.

In recognition for him now agreeing to remain with Sigma until the end of January 2022, Sigma has agreed to increase Mr Hooper’s monthly total fixed remuneration for the three-month period by 50 per cent.

Sigma Healthcare was trading 1.64 per cent lower at 60 cents at 11:37 am AEST.

SIG by the numbers
More From The Market Online

This stock provides Oz’s only HIV self-test kit – and it’s bullish on the budget

Atomo Diagnostics is the only company in Australia that provides TGA-approved HIV self-test kits. It says…

Recce Pharma heading closer to full efficacy data for flagship R327

Recce Pharma has announced the latest cohort of patients in the company's Phase I/II UTI trial…
The Market Online Video

Breaking barriers in cancer treatment: Race Oncology pioneers a new era with bisantrene

Race Oncology (ASX:RAC) has announced positive results in killing cancer cells in combination with the drug…

Optiscan agreement with Mayo Clinic aims to expedite robotic surgery

Optiscan Imaging is parterning with Mayo Clinic to develop a digital confocal laser endomicroscopic imaging system